← Browse by Condition
Medical Condition

autism

Total Trials
13
Recruiting Now
13
Trial Phases
Phase 2, Phase 3

Autism spectrum disorder (ASD) trials target core symptoms (social communication, restricted/repetitive behaviors) as well as co-occurring conditions including anxiety, sleep disturbance, and gastrointestinal problems. The heterogeneity of ASD β€” driven by hundreds of genetic variants β€” has driven interest in genotype-stratified trials that enroll specific genetic subtypes (SHANK3, CHD8, FMR1).

Trials evaluate oxytocin nasal spray, vasopressin receptor modulators, mGluR5 antagonists in fragile X, bumetanide (GABA modulator), transcranial magnetic stimulation, and early intensive behavioral interventions. Biomarkers including EEG connectivity measures and eye-tracking are being validated as objective outcome measures.

Frequently Asked Questions — autism Clinical Trials

How many clinical trials are currently recruiting for autism?
ClinicalMetric currently tracks 13 actively recruiting clinical trials for autism, sourced in real time from ClinicalTrials.gov. The total number of registered studies—including those not yet enrolling or in active follow-up—is 13. Trial availability changes daily as new studies open enrollment and existing ones reach capacity.
What trial phases are available for autism?
autism research spans Phase 2 (1 trial), Phase 3 (1 trial). Phase 1 studies evaluate safety and dosing in small groups, Phase 2 studies assess preliminary efficacy in 100–300 participants, and Phase 3 trials compare the new treatment against the standard of care in 300–3,000+ patients. Phase 4 post-approval studies monitor long-term outcomes in real-world populations.
How do I find out if I qualify for a autism clinical trial?
Eligibility criteria for autism trials vary by study and typically specify age range, disease stage or severity, prior treatment history, and specific diagnostic or laboratory parameters. Each listing on ClinicalMetric links to the full protocol on ClinicalTrials.gov, where inclusion and exclusion criteria are documented. Contact the sponsoring site's research coordinator directly to confirm your eligibility—your treating physician or specialist can also help identify the most appropriate trial based on your medical history and current treatment status.
Trial Phases
Phase 2
1
Phase 3
1
Top Sponsors
Stanford University 2 trials
Friendi.fi Corporation 1 trial
Istituto per la Ricerca e l'Innovazione Biomedica 1 trial
Emory University 1 trial
Fondazione I.R.C.C.S. Istituto Neurologico Carlo Besta 1 trial

Recruiting Clinical Trials

NCT03583684
Recruiting
Neuroimaging Predictors of Improvement to Pivotal Response Treatment (PRT) in Young Children With Autism
Enrollment
36 pts
Location
United States
Sponsor
Stanford University
View Trial →
NCT07533331
Recruiting
Testing Conversational Agents as a Digital Companion
Enrollment
38 pts
Location
United States
Sponsor
Friendi.fi Corporation
View Trial →
NCT06872229
Recruiting
The Impact of Sensory Integration on Attention in Autism
Enrollment
100 pts
Location
Italy
Sponsor
Istituto per la Ricerca e l'In...
View Trial →
NCT07148258
Recruiting
Evaluating Georgia Part C Implementation Outcomes
Enrollment
20 pts
Location
United States
Sponsor
Emory University
View Trial →
NCT04532424
Recruiting
Transcranial Magnetic Stimulation for Restricted and Repetitive Behavior in ASD
Enrollment
67 pts
Location
United States
Sponsor
Stanford University
View Trial →
NCT07450443 Phase 2, Phase 3
Recruiting
Role of the Gut Vascular Barrier and Microbiota in Autism Spectrum Disorders
Enrollment
90 pts
Location
Italy
Sponsor
Fondazione I.R.C.C.S. Istituto...
View Trial →
NCT06255925
Recruiting
A Strength-Based Employment Maintenance Program for Individuals on the Autism Spectrum
Enrollment
30 pts
Location
United States
Sponsor
Kessler Foundation
View Trial →
NCT07042347
Recruiting
Testing a Measurement Feedback App to Improve Data Quality, Supervision & Outcomes in Behavioral Health
Enrollment
200 pts
Location
United States
Sponsor
University of Pennsylvania
View Trial →
NCT06649916
Recruiting
Word Learning From Parentese in Autistic Children
Enrollment
100 pts
Location
United States
Sponsor
The University of Texas at Dal...
View Trial →
NCT06823492
Recruiting
Investigating the Impacts of Early Life Experience on the Brain & Behaviour
Enrollment
120 pts
Location
United Kingdom
Sponsor
University of Manchester
View Trial →
NCT06705907
Recruiting
Improving Academic and Social Functioning in Middle-Schoolers With Autism
Enrollment
224 pts
Location
United States
Sponsor
Children's Hospital Medical Ce...
View Trial →
NCT07137273
Recruiting
Optimizing Dimensions of Reinforcement
Enrollment
30 pts
Location
United States
Sponsor
Auburn University
View Trial →
NCT00271622
Recruiting
The Neurodevelopmental and Behavioral Phenotyping Screening Protocol
Enrollment
5,000 pts
Location
United States
Sponsor
National Institute of Mental H...
View Trial →

Related Conditions

autism spectrum disorder (5) adhd (2) communication disorder childhood (1) asperger syndrome (1) autism disorder (1) autism spectrum disorder asd (1) challenging behavior (1) oppositional defiant disorder (1) neurodevelopmental disorders (1) mental health (1) neurodevelopment (1) depression major depressive disorder (1)
ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: November 2026  ·  Data Methodology